Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: A Phase 2, Open-label, Safety, Tolerability, and Efficacy Trial of a Botanical Drug At One Dose Level for the Treatment of External Condylomata Acuminata (Genital Warts) i
Brief Summary: This trial will be a phase 2, open-label, study to evaluate the safety, tolerability, and efficacy of VIR007 when administered topically for up to 60 days to adults between the ages of 18 to 65 years with a clinical diagnosis of external condylomata acuminata.